Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelomonocytic, Chronic

Explore clinical trials studying Leukemia, Myelomonocytic, Chronic. Study availability and eligibility vary by location and protocol.

20 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelomonocytic, Chronic trial results

Completed

Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment)

NCT02085798

Conditions
Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +23 more
Locations
  • Hospital Universitario Txagorritxu Vitoria-Gasteiz, Alava, Spain
  • Hospital Universitario La Ribera Alzira, Alicante, Spain
  • Hospital Universitari Germans Trias I Pujol Badalona, Barcelona, Spain
  • Complejo Hospitalrio La Mancha Centro Alcázar de San Juan, Ciudad Real, Spain
View all 50 locations
View Trial Details
Completed

Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine

NCT01519011

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
Locations
  • Moores UCSD Cancer Center MC-0987 La Jolla, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Comprehensive Cancer Centers of Nevada Las Vegas, Nevada, United States
  • University of Cincinnati Physician's Inc. Cincinnati, Ohio, United States
View Trial Details
Completed

Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma

NCT00761722

Conditions
Acute Myeloid Leukemia, Blood Protein Disorders, Bone Marrow Diseases, +26 more
Locations
  • California Cancer Care Inc Greenbrae, California, United States
  • Main Cancer Centers of Florida, P.A. Ocoee, Florida, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
View Trial Details
Completed

Volasertib in Combination With Azacitidine in Japanese Patients With Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

NCT02201329

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Boehringer Ingelheim Investigational Site Aichi, Nagoya, Japan
  • Boehringer Ingelheim Investigational Site Gunma, Maebashi, Japan
  • Boehringer Ingelheim Investigational Site Nagasaki, Nagasaki, Japan
  • Boehringer Ingelheim Investigational Site Tokyo, Sinagawa-ku, Japan
View Trial Details
Active, Not Recruiting

Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.

NCT05201066

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Oregon Health Sciences University Portland, Oregon, United States
  • Huntsman Cancer Institute Univ of Utah Salt Lake City, Utah, United States
  • Novartis Investigative Site Clayton, Victoria, Australia
  • Novartis Investigative Site Florianópolis, Santa Catarina, Brazil
View all 24 locations
View Trial Details
Active, Not Recruiting

A Study Comparing Treatment Preference Between Oral Decitabine/Cedazuridine and Azacitidine in Myelodysplastic Syndrome, Low-Blast Acute Myeloid Leukemia, or Chronic Myelomonocytic Leukemia

NCT05883956

Conditions
Behavior, Bone Marrow Diseases, Chronic Disease, +17 more
Locations
  • Calvary Mater Newcastle Newcastle, New South Wales, Australia
  • Pindara Private Hospital Benowa, Queensland, Australia
  • Townsville Hospital Townsville, Queensland, Australia
  • Adelaide Oncology and Haematology North Adelaide, South Australia, Australia
View Trial Details

Related conditions